Fiamma Buttitta

Fiamma Buttitta

UNVERIFIED PROFILE

Are you Fiamma Buttitta?   Register this Author

Register author
Fiamma Buttitta

Fiamma Buttitta

Publications by authors named "Fiamma Buttitta"

Are you Fiamma Buttitta?   Register this Author

47Publications

1218Reads

8Profile Views

Why anti-PD1/PDL1 therapy is so effective? Another piece in the puzzle.

J Thorac Dis 2017 Dec;9(12):4863-4866

Center of Predictive Molecular Medicine, CeSI-MeT, University of Chieti, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.11.105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756957PMC
December 2017

ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.

J Thorac Oncol 2016 Apr 22;11(4):487-95. Epub 2016 Feb 22.

Oncological and Cardiovascular Molecular Medicine Unit, Center for Excellence on Ageing and Translational Medicine, University of Chieti-Pescara, Chieti, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.12.111DOI Listing
April 2016

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.

PLoS One 2014 19;9(8):e103883. Epub 2014 Aug 19.

Center of Predictive Molecular Medicine, Center of Excellence on Aging, University-Foundation, Chieti, Italy; Oncological and Cardiovascular Molecular Medicine Unit, Center of Excellence on Aging, University-Foundation, Chieti, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103883PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138040PMC
October 2015

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.

J Thorac Oncol 2015 Oct;10(10):1437-43

*Center of Predictive Molecular Medicine, Ce.S.I., G. D'Annunzio University-Foundation, Chieti, Italy; †Medical Scientific Affairs Department, Roche Molecular Systems, Pleasanton, California; ‡Oncological and Cardiovascular Molecular Medicine Unit, Ce.S.I., G. D'Annunzio University-Foundation, Chieti, Italy; §Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy; ‖Department of Medical Oncology, S. Maria della Misericordia Hospital, Perugia, Italy; ¶Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL of Bologna, Bologna, Italy; #Unit of Pneumology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; **Ospedale Civile di Pescara, Pescara, Italy; ††Ospedale Civile di Sulmona, Sulmona, Italy; ‡‡Department of Medical Oncology, Consorzio Interuniversitario Nazionale per la Bio-Oncologia, G. d'Annunzio University, Chieti, Italy; §§Department of Oncology-Haematology, Humanitas Cancer Center, IRCCS, Milan, Italy; and ‖‖Perugia University Medical School, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000643DOI Listing
October 2015

ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance scheme.

J Thorac Oncol 2014 Oct;9(10):1470-6

*Center of Predictive Molecular Medicine, Center of Excellence on Aging, University-Foundation, Chieti, Italy; †Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; ‡Division of Anatomic Pathology, San Luigi Hospital and University of Turin, Orbassano, Italy; §Pathology Department, Policlinico di Modena, Modena, Italy; ‖Diagnostic and Laboratory Medicine, INT-Fondazione "G.Pascale", Naples, Italy; ¶Medical Oncology Unit, University Hospital, Parma, Italy; #Department of Medical Oncology, Perugia Hospital, Perugia, Italy; **Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy; ††Department of Human Pathology and Oncology, University of Florence, Florence, Italy; ‡‡Pathology Department, Casa di Cura San Pio X and I.R.C.C.S. Policlinico San Donato, Milano, Italy; §§Thoracic Oncology Unit, University of Torino, San Luigi Hospital, Torino, Italy; ‖‖Cell Biology and Biotherapy Unit, INT-Fondazione "G.Pascale", Naples, Italy; and ¶¶Medical Oncology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000280DOI Listing
October 2014

Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control.

J Clin Endocrinol Metab 2014 Sep 17;99(9):E1681-5. Epub 2014 Jun 17.

Geriatric Clinic, European Center of Excellence on Atherosclerosis, Hypertension and Dyslipidemia, (D.S., V.D.N., P.M., C.M., C.P., E.V., M.B., A.M., F.C.) Clinical Research Center, Center of Excellence on Aging (D.S., V.D.N., P.M., C.M., C.P., M.B., A.M., A.C., F.C.), Center of Predictive Molecular Medicine, Center of Excellence on Aging (F.B.), Diabetes and Metabolism Unit, Department of Medicine and Aging Sciences (A.C.), "G. d'Annunzio" University, 66100 Chieti, Italy; and Institute for Cardiovascular Prevention (D.S.), Ludwig-Maximilians University, 80336 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2013-3843DOI Listing
September 2014

microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer.

J Thorac Oncol 2013 Sep;8(9):1156-62

Center of Predictive Molecular Medicine, Center of Excellence on Aging, †Oncological and Cardiovascular Molecular Medicine Unit, University-Foundation, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318299ac32DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123222PMC
September 2013

A unique microRNA signature associated with plaque instability in humans.

Stroke 2011 Sep 4;42(9):2556-63. Epub 2011 Aug 4.

Centro di Eccellenza Europeo e di Riferimento Regionale per l'Aterosclerosi, l'Ipertensione Arteriosa e le Dislipidemie, Nuovo Policlinico SS, Annunziata, Via dei Vestini 66, 66013 Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.110.597575DOI Listing
September 2011

Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.

J Clin Oncol 2011 Sep 8;29(26):3574-9. Epub 2011 Aug 8.

Center of Predictive Molecular Medicine, Center of Excellence on Aging (CeSI) University-Foundation, via Colle dell'Ara, 66100 Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.35.9638DOI Listing
September 2011

Mutational profile of GNAQQ209 in human tumors.

PLoS One 2009 Aug 31;4(8):e6833. Epub 2009 Aug 31.

Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Torino Medical School, University of Torino, Medical School Candiolo, Torino, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006833PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730032PMC
August 2009

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients.

J Clin Oncol 2009 Apr 2;27(10):1667-74. Epub 2009 Mar 2.

Istituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico, Department of Oncology-Hematology, University of Milan School of Medicine, IRCCS Istituto Clinico Humanitas, Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.1635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341799PMC
April 2009

Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.

Clin Cancer Res 2007 Oct;13(20):6064-9

Unit of Surgical Pathology, Laboratory of Molecular Pathology S. Chiara Hospital, Trento, Italy, and Clinical Research Center, Center of Excellence on Aging, University-Foundation, Chieti, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0266DOI Listing
October 2007

Assessing EGFR mutations.

N Engl J Med 2006 Feb;354(5):526-8; author reply 526-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc052564DOI Listing
February 2006

HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry.

Clin Cancer Res 2003 Sep;9(10 Pt 1):3645-52

Division of Pathology, Department of Medicine, Surgery and Dental Sciences, University of Milan, A.O. S. Paolo and IRCCS Ospedale Maggiore, 20142 Milan, Italy

View Article

Download full-text PDF

Source
September 2003

Survivin gene expression in early-stage non-small cell lung cancer.

J Pathol 2003 Aug;200(5):620-6

Department of Medicine, Surgery and Dental Sciences, Division of Pathology, University of Milan, AO S Paolo, Via A Di Rudini 8, 20142 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1388DOI Listing
August 2003